Sermorelin + Ipamorelin Blend Vials
|Molar Mass||3357.93 g·mol−1|
|Molar Mass||711.868 g·mol−1|
The Sermorelin + Ipamorelin Blend is a research peptide combination developed exclusively for scientific investigation. Engineered to explore potential synergies and applications in growth hormone regulation, this blend provides researchers with a tool to delve into physiological processes related to growth hormones.
Sermorelin is a growth hormone-releasing peptide designed to stimulate the body’s natural production of growth hormone. Ipamorelin is known for its growth hormone-stimulating properties, Ipamorelin complements Sermorelin in this blend.
This research peptide blend is formulated for investigations into growth hormone-related processes. Researchers may utilize it to explore potential synergistic effects and understand its impact on various physiological aspects.
Potential for Synergistic Benefit
Studies may focus on the combined effects of Sermorelin and Ipamorelin, exploring potential synergies in stimulating growth hormone release.
Sermorelin and GH
Researchers may investigate the specific impact of Sermorelin on growth hormone production, contributing to a deeper understanding of its regulatory mechanisms.
Ipamorelin and Weight Gain
The research may delve into Ipamorelin’s potential impact on weight gain, providing insights into its applications for metabolic processes.
The Sermorelin + Ipamorelin Blend is a research peptide combination engineered for scientific exploration into growth hormone-related processes. With a focus on potential synergistic benefits, researchers are encouraged to investigate its effects on growth hormone stimulation, metabolic aspects, and more.
- Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489. [Read More].
- Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992 Aug;75(2):530-5. doi: 10.1210/jcem.75.2.1379256. PMID: 1379256. [Read More].